Kytta-Sedativum Für Den Tag

Passion flower (Passiflora incarnata) dry extract, the active ingredient in Kytta-Sedativum Für Den Tag, is a herbal sedative presented as a dry extract for oral use. It is used to support mild anxiety, occasional insomnia and restlessness in adults.\n\nGNH India supplies Kytta-Sedativum Für Den Tag as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kytta‑Sedativum Für Den Tag, a herbal sedative derived from passion flower, acts on the GABAergic system to alleviate mild anxiety‑related conditions.\n\n- Mild anxiety: helps reduce nervous tension and promote calmness.\n- Insomnia: supports falling asleep more easily and improves sleep quality.\n- Restlessness: eases agitation and promotes a sense of relaxation.

Kytta‑Sedativum Für Den Tag may cause several adverse reactions, most of which are mild and reversible.\n\nCommon Side Effects:\n- Drowsiness: mild sleepiness during the day.\n- Dizziness: transient light‑headed feeling.\n- Gastrointestinal discomfort: mild nausea or stomach upset.\n- Headache: occasional mild headache.\n\nSerious or Rare Side Effects:\n- Allergic reaction: rash, itching, swelling, or difficulty breathing.\n- Hepatic dysfunction: elevated liver enzymes (rare).\n- Severe hypotension: unusually low blood pressure (very rare).

When considering Kytta‑Sedativum Für Den Tag, certain precautions should be observed to ensure safe use.\n\n- Pregnancy: safety not established; avoid use unless clearly needed.\n- Breastfeeding: unknown safety; consult healthcare professional.\n- Concomitant CNS depressants: may enhance sedative effect, monitor closely.\n- Liver impairment: use with caution as metabolism may be affected.\n- Elderly patients: start with lower dose and monitor for excessive sedation.\n- Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and light.

Kytta‑Sedativum Für Den Tag can interact with other substances that affect the central nervous system.\n\nMajor Interactions (Avoid):\n- Benzodiazepines: additive sedation and respiratory depression.\n- Barbiturates: increased risk of profound CNS depression.\n- Alcohol: potentiates drowsiness and impairment.\n\nModerate Interactions (Monitor Closely):\n- Antihistamines: may increase drowsiness.\n- Opioid analgesics: enhanced sedative effect.\n- Antidepressants (SSRIs): possible increase in serotonergic activity, monitor for serotonin syndrome.